SINGLE-CELL ANALYSIS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-199034 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Single-cell Analysis Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL SINGLE-CELL ANALYSIS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL SINGLE-CELL ANALYSIS MARKET
7.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Becton, Dickinson and Company (US)
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Danaher Corporation (US)
16.3 Merck Millipore (US)
16.4 QIAGEN (Netherlands)
16.5 Thermo Fisher Scientific (US)
16.6 General Electric Company (US)
16.7 10x Genomics (US)
16.8 Promega Corporation (US)
16.9 Illumina (US)
16.10 Bio-Rad Laboratories (US)
16.11 Fluidigm Corporation (US)
16.12 Agilent Technologies (US)
16.13 NanoString Technologies (US)
16.14 Tecan Group (Switzerland)
16.15 Sartorius AG (Germany)
16.16 Luminex Corporation (US)
16.17 Takara Bio (Japan)
16.18 Fluxion Biosciences (US)
16.19 Menarini Silicon Biosystems (Italy)
16.20 LumaCyte (US)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By ProductConsumables
 o Beads
 o Microplates
 o Reagents
 o Assay Kits
   o Immunoassays
   o Cell-based Assays
 o Other Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials, Filtration Apparatus, Petri Dishes, Inserts, and Discs)
Instruments
 o Flow Cytometers
 o NGS Systems
 o PCR Instruments
 o Spectrophotometers
 o Microscopes
 o Cell Counters
 o HCS Systems
 o Microarrays
 o Other Instruments (Laser Capture Microdissection (LCM) Systems, Micromanipulation Devices, and Integrated Fluidic Circuits (IFCs))
By Cell Type
Human Cells
Animal Cells
Microbial Cells
By Technique
Flow Cytometry
Next-generation Sequencing
Polymerase Chain Reaction
Microscopy
Mass Spectrometry
Other Techniques (Fluorescence In Situ Hybridization (FISH), Capillary Electrophoresis (CE), Single-Molecule Fluorescence In Situ Hybridization (smFISH), and Micromanipulation)
By Application
Research Applications
 o Cancer
 o Immunology
 o Neurology
 o Stem Cell
 o Other ResearchApplications (Tissue Regeneration, Drug Discovery, and Research on Aging)
Medical Applications
 o Noninvasive Prenatal Diagnosis
 o in Vitro Fertilization
 o Circulating Tumor Cell Detection
By End User
Academic & Research Laboratories
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostic Laboratories
Cell Banks & IVF Centers
Companies
Becton, Dickinson and Company (US)
Danaher Corporation (US)
Merck Millipore (US)
QIAGEN (Netherlands)
Thermo Fisher Scientific (US)
General Electric Company (US)
10x Genomics (US)
Promega Corporation (US)
Illumina (US)
Bio-Rad Laboratories (US)
Fluidigm Corporation (US)
Agilent Technologies (US)
NanoString Technologies (US)
Tecan Group (Switzerland)
Sartorius AG (Germany)
Luminex Corporation (US)
Takara Bio (Japan)
Fluxion Biosciences (US)
Menarini Silicon Biosystems (Italy)
LumaCyte (US)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.